# Study of Dexamethasone-Allantoin-Metronidazole (DAM) Solution in the Treatment of Post-Operative Ileus (POI)

> **NCT01863407** · PHASE3 · UNKNOWN · sponsor: **Beijing Bozhiyin T&S Co., Ltd.** · enrollment: 480 (estimated)

## Conditions studied

- Postoperative Ileus

## Interventions

- **DRUG:** DAM
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT01863407
- **Lead sponsor:** Beijing Bozhiyin T&S Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2013-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01863407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01863407, "Study of Dexamethasone-Allantoin-Metronidazole (DAM) Solution in the Treatment of Post-Operative Ileus (POI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01863407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*